Fierce’s coverage of the Martin Shkreli saga

Alok Saboo

's controversial Turing Pharmaceuticals made global headlines this week after the startup chose to jack up the price of a decades-old drug to boost revenue, and the company's unapologetic CEO took on all critics in media traditional and new. Here's a timeline of how it all went down.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS